financial post
U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
Financial Post • 6 MONTHS AGO
‘Not meant to be’: Manitoba Museum reflects as Bay charter heads elsewhere
Financial Post • 6 MONTHS AGO
RioCan pulls financial support for some properties in Hudson’s Bay joint venture
Financial Post • 6 MONTHS AGO
The Joan Rivers Joke File Exhibit Opens at the National Comedy Center on Saturday, Aug 9
Financial Post • 6 MONTHS AGO
Opinion: If Trump’s trade target is a customs union, Canada will have a big decision to make
Financial Post • 6 MONTHS AGO
A Florida woman posed as a nurse and treated thousands of unsuspecting patients, officials say
Financial Post • 6 MONTHS AGO
ShariaPortfolio Wealth Group Surpasses $2 Billion in Assets Under Management
Financial Post • 6 MONTHS AGO